These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 286623)

  • 1. Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.
    Al-Ismail S; Whittaker JA
    Br Med J; 1979 May; 1(6175):1392-5. PubMed ID: 286623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals.
    Villani F; Beretta G; Guindani A
    Cancer Chemother Pharmacol; 1979; 3(4):249-51. PubMed ID: 535135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin cardiotoxicity. Prognostic value of the systolic time intervals.
    Chaudron JM; Beauduin M; Delwiche JP; Delannoy A; Luwaert R; Majois F; Lebacq EG; Pluygers E
    Acta Cardiol; 1982; 37(2):105-15. PubMed ID: 6980547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.
    Hausdorf G; Morf G; Beron G; Erttmann R; Winkler K; Landbeck G; Keck EW
    Br Heart J; 1988 Oct; 60(4):309-15. PubMed ID: 3190959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of doxorubicin cardiotoxicity in patients treated intermittently with beta-methyldigoxin.
    Villani F; Comazzi R; Di Fronzo G; Bertuzzi A; Guindani A
    Tumori; 1982 Aug; 68(4):349-53. PubMed ID: 7147362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ; Bailey C; Wood D; Donaldson MH
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.
    Bristow MR; Mason JW; Billingham ME; Daniels JR
    Ann Intern Med; 1978 Feb; 88(2):168-75. PubMed ID: 626445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of systolic time intervals in healthy and in adriamycin-treated children].
    Kasih EN; Hoffmann W
    Klin Padiatr; 1984; 196(6):360-6. PubMed ID: 6513423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
    Pinna A; Agen C; Di Paolo A; Innocenti F; Nardini D; Danesi R; Del Tacca M
    J Environ Pathol Toxicol Oncol; 1994; 13(1):25-31. PubMed ID: 7823290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.
    Jensen RA; Acton EM; Peters JH
    J Cardiovasc Pharmacol; 1984; 6(1):186-200. PubMed ID: 6199603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flunarizine on the delayed cardiotoxicity of doxorubicin in rats.
    Villani F; Galimberti M; Monti E; Piccinini F; Poggi P; Lanza E; Rozza A; Favalli L
    Pharmacol Res; 1991 Feb; 23(2):195-202. PubMed ID: 2062794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration.
    Ewer MS; Jaffe N; Ried H; Zietz HA; Benjamin RS
    Med Pediatr Oncol; 1998 Dec; 31(6):512-5. PubMed ID: 9835904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicity.
    Lum BL; Svec JM; Torti FM
    Drug Intell Clin Pharm; 1985 Apr; 19(4):259-64. PubMed ID: 3891276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.